Ixekizumab/ Anti-IL-17A (Taltz) is a humanized IgG4 biosimilar monoclonal antibody expressed by mammalian cell lines that block the biological activity of IL-17A. IL-17A is a pro-inflammatory cytokine that triggers immune cells like neutrophils, lymphocy
Clonality:
Monoclonal
Isotype:
IgG4
Purity:
Purified from cell culture supernatant by affinity chromatography
Application Dilute:
ELISA 1:5000-10000, FACS 1:100
* VAT and and shipping costs not included. Errors and price changes excepted